Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
05/04/2023 | IRLAB Therapeutics AB | Joakim Tedroff | Other senior executive | Yes | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 03/04/2023 | 51,430 | Quantity | 39.64 | SEK | Notification | |
28/02/2023 | IRLAB Therapeutics AB | Cecilia Tivert Stenberg | Chief Financial Officer (CFO) | Disposal | IRLAB BTA A | Share | SE0013748332 | 28/02/2023 | 20,000 | Quantity | 10.90 | SEK | Notification | ||
05/09/2022 | IRLAB Therapeutics AB | Richard Godfrey | Chief Executive Officer (CEO)/Managing Directory | Yes | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 01/09/2022 | 5,000 | Quantity | 34.8914 | SEK | Notification | |
30/08/2022 | IRLAB Therapeutics AB | Viktor Siewertz | Chief Financial Officer (CFO) | Yes | Disposal | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 29/08/2022 | 40 | Quantity | 35.20 | SEK | Notification | |
30/08/2022 | IRLAB Therapeutics AB | Viktor Siewertz | Chief Financial Officer (CFO) | Yes | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 30/08/2022 | 40 | Quantity | 35.50 | SEK | Notification | |
16/07/2022 | IRLAB Therapeutics AB | Joakim Tedroff | Other senior executive | Division of joint property between spouses decrease | IRLAB THERAPEUTICS A | Share | SE0012675361 | 15/07/2022 | 84,148 | Quantity | 0.00 | SEK | Notification | ||
31/05/2022 | IRLAB Therapeutics AB | Viktor Siewertz | Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 27/05/2022 | 3,000 | Quantity | 38.93 | SEK | Notification | ||
31/05/2022 | IRLAB Therapeutics AB | Viktor Siewertz | Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 30/05/2022 | 3,000 | Quantity | 40.16 | SEK | Notification | ||
31/05/2022 | IRLAB Therapeutics AB | Viktor Siewertz | Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 31/05/2022 | 4,500 | Quantity | 37.86 | SEK | Notification | ||
26/02/2022 | IRLAB therapeutics AB | Carola Elisabet Lemne | Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A | Share | SE0012675361 | 25/02/2022 | 10,000 | Quantity | 32.95 | SEK | History | Notification |